blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3115454

EP3115454 - NOVEL RNA SEQUENCE HAVING ANTI-TUMOUR ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.12.2020
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  10.01.2020
FormerGrant of patent is intended
Status updated on  28.08.2019
FormerExamination is in progress
Status updated on  12.10.2018
FormerRequest for examination was made
Status updated on  09.12.2016
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Yamamoto, Hirofumi
Graduate School of Medicine
Department of Gastroenterological Surgery
E-2 2-2 Yamadaoka
Suita-shi, Osaka 565-0871 / JP
For all designated states
Mori, Masaki
Graduate School of Medicine
Department of Gastroenterological Surgery E-2
2-2 Yamadaoka
Suita-shi, Osaka 565-0871 / JP
[2017/02]
Inventor(s)01 / YAMAMOTO, Hirofumi
c/o OSAKA UNIVERSITY, Graduate School of Medicine
Department of Gastroenterological Surgery
E-2, 2-2, Yamadaoka
Suita-shi, Osaka 565-0871 / JP
02 / MORI, Masaki
c/o OSAKA UNIVERSITY,Graduate School of Medicine
Department of Gastroenterological Surgery
E-2, 2-2, Yamadaoka
Suita-shi, Osaka 565-0871 / JP
03 / DOKI, Yuichiro
c/o OSAKA UNIVERSITY
1-1 Yamadaoka
Suita-shi Osaka 565-0871 / JP
 [2020/07]
Former [2017/02]01 / YAMAMOTO, Hirofumi
Graduate School of Medicine
Department of Gastroenterological Surgery
E-2 2 2 Yamadaoka
Suita-shi Osaka 565-0871 / JP
02 / MORI, Masaki
Graduate School of Medicine
Department of Gastroenterological Surgery
E-2 2 2 Yamadaoka
Suita-shi Osaka 565-0871 / JP
03 / DOKI, Yuichiro
c/o OSAKA UNIVERSITY
1-1 Yamadaoka
Suita-shi Osaka 565-0871 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/02]
Application number, filing date15757718.004.03.2015
[2017/02]
WO2015JP56352
Priority number, dateJP2014004176904.03.2014         Original published format: JP 2014041769
[2017/02]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015133521
Date:11.09.2015
Language:JA
[2015/36]
Type: A1 Application with search report 
No.:EP3115454
Date:11.01.2017
Language:EN
[2017/02]
Type: B1 Patent specification 
No.:EP3115454
Date:12.02.2020
Language:EN
[2020/07]
Search report(s)International search report - published on:JP11.09.2015
(Supplementary) European search report - dispatched on:EP17.07.2017
ClassificationIPC:C12N15/00, A61K9/14, A61K31/7088, A61K47/02, A61K48/00, A61P35/00, C12N15/09, A61K9/51, A61K9/00, C12N15/113
[2017/33]
CPC:
C12N15/113 (EP,US); A61K47/02 (EP,US); A61K9/0019 (EP,US);
A61K9/5115 (EP,US); A61P1/00 (EP); A61P35/00 (EP);
C12N2310/141 (EP,US); C12N2310/351 (US) (-)
Former IPC [2017/02]C12N15/00, A61K9/14, A61K31/7088, A61K47/02, A61K48/00, A61P35/00, C12N15/09
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/02]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:NEUARTIGE RNA-SEQUENZ MIT ANTITUMORWIRKUNG[2017/02]
English:NOVEL RNA SEQUENCE HAVING ANTI-TUMOUR ACTIVITY[2017/02]
French:NOUVELLE SÉQUENCE D'ARN POSSÉDANT UNE ACTIVITÉ ANTI-TUMORALE[2017/02]
Entry into regional phase28.09.2016Translation filed 
28.09.2016National basic fee paid 
28.09.2016Search fee paid 
28.09.2016Designation fee(s) paid 
28.09.2016Examination fee paid 
Examination procedure28.09.2016Examination requested  [2017/02]
28.09.2016Date on which the examining division has become responsible
13.02.2018Amendment by applicant (claims and/or description)
12.10.2018Despatch of a communication from the examining division (Time limit: M04)
13.02.2019Reply to a communication from the examining division
29.08.2019Communication of intention to grant the patent
20.12.2019Fee for grant paid
20.12.2019Fee for publishing/printing paid
20.12.2019Receipt of the translation of the claim(s)
Opposition(s)13.11.2020No opposition filed within time limit [2021/03]
Fees paidRenewal fee
13.03.2017Renewal fee patent year 03
21.03.2018Renewal fee patent year 04
15.03.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.03.2015
AL12.02.2020
AT12.02.2020
CY12.02.2020
CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
IT12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
MK12.02.2020
MT12.02.2020
NL12.02.2020
PL12.02.2020
RO12.02.2020
RS12.02.2020
SI12.02.2020
SK12.02.2020
SM12.02.2020
TR12.02.2020
IE04.03.2020
LU04.03.2020
BE31.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
[2022/31]
Former [2022/30]HU04.03.2015
AL12.02.2020
AT12.02.2020
CY12.02.2020
CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
IT12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
MT12.02.2020
NL12.02.2020
PL12.02.2020
RO12.02.2020
RS12.02.2020
SI12.02.2020
SK12.02.2020
SM12.02.2020
TR12.02.2020
IE04.03.2020
LU04.03.2020
BE31.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2022/27]HU04.03.2015
AT12.02.2020
CY12.02.2020
CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
IT12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
MT12.02.2020
NL12.02.2020
PL12.02.2020
RO12.02.2020
RS12.02.2020
SI12.02.2020
SK12.02.2020
SM12.02.2020
TR12.02.2020
IE04.03.2020
LU04.03.2020
BE31.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2021/10]AT12.02.2020
CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
IT12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
NL12.02.2020
PL12.02.2020
RO12.02.2020
RS12.02.2020
SI12.02.2020
SK12.02.2020
SM12.02.2020
IE04.03.2020
LU04.03.2020
BE31.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2021/08]CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SK12.02.2020
SM12.02.2020
IE04.03.2020
LU04.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2021/04]CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SK12.02.2020
SM12.02.2020
LU04.03.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2020/52]CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
MC12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SK12.02.2020
SM12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2020/50]CZ12.02.2020
DK12.02.2020
EE12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SK12.02.2020
SM12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2020/49]CZ12.02.2020
DK12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SK12.02.2020
SM12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2020/48]DK12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
NL12.02.2020
RO12.02.2020
RS12.02.2020
SM12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
PT05.07.2020
Former [2020/47]DK12.02.2020
ES12.02.2020
FI12.02.2020
HR12.02.2020
LT12.02.2020
LV12.02.2020
NL12.02.2020
RS12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
Former [2020/45]FI12.02.2020
HR12.02.2020
LV12.02.2020
NL12.02.2020
RS12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
Former [2020/40]FI12.02.2020
HR12.02.2020
LV12.02.2020
RS12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
IS12.06.2020
Former [2020/39]FI12.02.2020
HR12.02.2020
LV12.02.2020
RS12.02.2020
BG12.05.2020
NO12.05.2020
GR13.05.2020
Former [2020/38]FI12.02.2020
HR12.02.2020
LV12.02.2020
RS12.02.2020
NO12.05.2020
GR13.05.2020
Former [2020/37]FI12.02.2020
HR12.02.2020
LV12.02.2020
RS12.02.2020
NO12.05.2020
Former [2020/35]FI12.02.2020
NO12.05.2020
Documents cited:Search[Y]WO2011130464  (ABRAXIS BIOSCIENCE LLC [US], et al) [Y] 1-10 * paragraph [0104] * * paragraph [0175] * * claims 1-43 *;
 [Y]US2012251619  (GUNARATNE PREETHI H [US]) [Y] 1-10 * paragraph [0016] - paragraph [0017] * * paragraph [0035] - paragraph [0036] *;
 [Y]  - HOSSAIN S ET AL, "Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 147, no. 1, ISSN 0168-3659, (20101001), pages 101 - 108, (20100708), XP027272150 [Y] 1-10 * the whole document, especially the abstract *
 [Y]  - GEERTRUI TAVERNIER ET AL, "mRNA as gene therapeutic: How to control protein expression", JOURNAL OF CONTROLLED RELEASE, (20110301), vol. 150, no. 3, doi:10.1016/j.jconrel.2010.10.020, ISSN 0168-3659, pages 238 - 247, XP055068617 [Y] 1-10 * right-hand column; page 242 *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2010.10.020
 [YP]  - "Abstract Book: Society of Surgical Oncology 69thAnnual Cancer Symposium", ANNALS OF SURGICAL ONCOLOGY, RAVEN PRESS, NEW YORK, NY, US, vol. 23, no. 1, doi:10.1245/S10434-015-5010-5, ISSN 1068-9265, (20160108), pages 1 - 195, (20160108), XP035897758 [YP] 1-10 * P100 *

DOI:   http://dx.doi.org/10.1245/s10434-015-5010-5
 [YP]  - XIAN-JUN SUN ET AL, "MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin", CELLULAR PHYSIOLOGY AND BIOCHEMISTRY., CH, (20150911), vol. 37, no. 2, doi:10.1159/000430389, ISSN 1015-8987, pages 707 - 718, XP055386972 [YP] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1159/000430389
International search[Y]JP2006509838  (The Circle for the Promotion of Science and Engineering) [Y] 7* , & WO 2004/043495 A1 *;
 [XY]WO2013109604  (ALNYLAM PHARMACEUTICALS INC [US]) [X] 1-6, 9-10 * , & US 2014/0363469 A * [Y] 5-7, 9;
 [Y]  - POUDYAL D. et al., "A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng", PLOS ONE, (20130000), vol. 8, no. 10, page e75034, XP055357961 [Y] 5-7, 9

DOI:   http://dx.doi.org/10.1371/journal.pone.0075034
 [Y]  - F ANG J. H. et al., "MicroRNA-29b Suppresses Tumor Angiogenesis, Invasion, and Metastasis by Regulating Matrix Metalloproteinase 2 Expression", Hepatology, (20110000), vol. 54, no. 5, ISSN 0270-9139, pages 1729 - 40, XP 055222863 [Y] 5-7, 9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.